A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

NCT06948994 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma
GD2 Antibody
Autologous NK Cell

Interventions

COMBINATION_PRODUCT: autologous NK cell plus GD2 antibody

Sponsor

Guangzhou Women and Children's Medical Center